Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study (Q35677669)
Jump to navigation
Jump to search
scientific article published on 14 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study |
scientific article published on 14 October 2014 |
Statements
1 reference
Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study (English)
1 reference
S-H Chien
1 reference
C-J Liu
1 reference
Y-C Hong
1 reference
C-J Teng
1 reference
Y-W Hu
1 reference
C-C Shen
1 reference
F-C Ku
1 reference
S-C Chen
1 reference
C-M Yeh
1 reference
T-J Chiou
1 reference
J-P Gau
1 reference
C-H Tzeng
1 reference
14 October 2014
1 reference
1 reference
112
1 reference
1
1 reference
177-184
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference